INTELLIA THERAPEUTICS, INC. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities
INTELLIA THERAPEUTICS, INC. (NTLA) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities of $321.00 thousand as of 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less)
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities · last filed 2024-02-22
- 2023-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities $321.00K.
- 2023-09-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities $321.00K.
- 2023-06-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities $321.00K.
- 2023-03-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities $321.00K.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities |
|---|---|
| 2023-12-31 | $321.00K 10-K · filed 2024-02-22 |
| 2023-09-30 | $321.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $321.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $321.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $321.00K 10-K · filed 2023-02-23 |
| 2022-09-30 | $321.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $321.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $321.00K 10-Q · filed 2022-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |